Accueil>>Signaling Pathways>> Metabolism>> phosphatases>>cyt-PTPε Inhibitor-1

cyt-PTPε Inhibitor-1

Catalog No.GC35791

cyt-PTPε L'inhibiteur-1 est un puissant inhibiteur de la protéine tyrosine phosphatase epsilon (cyt-PTPε) cytosolique, se lie au domaine catalytique de cyt-PTPε, bloque l'activation de c-Src (déphosphorylation de c-Src) et présente une activité anti-ostéoclastique.

Products are for research use only. Not for human use. We do not sell to patients.

cyt-PTPε Inhibitor-1 Chemical Structure

Cas No.: 428478-94-8

Taille Prix Stock Qté
100mg Please Inquire Please Inquire
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

cyt-PTPε Inhibitor-1 is a potent cytosolic protein tyrosine phosphatase epsilon (cyt-PTPε) inhibitor, binds to the catalytic domain of cyt-PTPε, blocks c-Src activation (dephosphorylation of c-Src), and exhibits anti-osteoclastic activity[1]. cyt-PTPε[1]

cyt-PTPε Inhibitor-1 (Compound 62) is a potent cytosolic protein tyrosine phosphatase epsilon with anti-osteoclastic activity[1].

[1]. Ku B, et al. Identification of N-(5-(phenoxymethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as novel protein tyrosine phosphatase epsilon inhibitors exhibiting anti-osteoclastic activity. ioorg Med Chem. 2018 Oct 1;26(18):5204-5211.

Avis

Review for cyt-PTPε Inhibitor-1

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for cyt-PTPε Inhibitor-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.